0001566028-13-000012.txt : 20130524 0001566028-13-000012.hdr.sgml : 20130524 20130524144940 ACCESSION NUMBER: 0001566028-13-000012 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130522 FILED AS OF DATE: 20130524 DATE AS OF CHANGE: 20130524 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Egbaria Kamel CENTRAL INDEX KEY: 0001490469 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-20424 FILM NUMBER: 13871684 MAIL ADDRESS: STREET 1: C/O HI-TECH PHARMACAL CO., INC. STREET 2: 369 BAYVIEW AVENUE CITY: AMITYVILLE STATE: NY ZIP: 11701 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HI TECH PHARMACAL CO INC CENTRAL INDEX KEY: 0000887497 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 112638720 STATE OF INCORPORATION: NY FISCAL YEAR END: 0430 BUSINESS ADDRESS: STREET 1: 369 BAYVIEW AVENUE CITY: AMITYVILLE STATE: NY ZIP: 11701 BUSINESS PHONE: 5167898228 MAIL ADDRESS: STREET 1: 369 BAYVIEW AVE. CITY: AMITYVILLE STATE: NY ZIP: 11701 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2013-05-22 0000887497 HI TECH PHARMACAL CO INC HITK 0001490469 Egbaria Kamel C/O HI-TECH PHARMACAL CO., INC. 369 BAYVIEW AVENUE AMITYVILLE NY 11701 0 1 0 0 Chief Scientific Officer, EVP Stock Option (Right to Buy) 33.81 2013-05-22 4 A 0 40000 0 A 2014-05-22 2023-05-22 Common Stock 40000 40000 D Stock Option granted under Hi-Tech Pharmacal Co., Inc.'s 2012 Incentive Compensation Plan, which is a Rule 16b-3 Plan. The option becomes exercisable in four (4) equal annual installments beginning on the first anniversary of the grant date. Other than the option reflected on this form, the filer is also the holder of additional options to acquire 148,658 shares of Hi-Tech Common Stock, which options were granted on various dates, with various exercise prices and exercisable and expiration dates. Kamel Egbaria 2013-05-24